Literature DB >> 11587791

From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides.

Y Shai1, Z Oren.   

Abstract

Living organisms of all types produce a large repertoire of gene-encoded, net positively charged, antimicrobial peptides as part of their innate immunity to microbial invasion. Despite significant variations in composition, length and secondary structure most antimicrobial peptides are active in micromolar concentrations, suggesting a common general mechanism for their mode of action. Many antimicrobial peptides bind bacterial phospholipid membranes up to a threshold concentration, followed by membrane permeation/disintegration (the "carpet" mechanism). Recent data suggest that the details of the permeation pathways may vary for different peptides and are assigned to different modes of action. Accumulating data reveal that the molecular basis for cell selectivity is the ability of peptides to specifically bind the negatively charged bacterial membrane, as well as their oligomeric state in solution and in the membrane. Based on the "carpet" mechanism and the role of the peptide oligomeric state, a novel group of diastereomeric (containing D- and L-amino acids) antimicrobial peptides were developed. These peptides may serve as promising templates for the future designs of antimicrobial peptides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587791     DOI: 10.1016/s0196-9781(01)00498-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  82 in total

1.  Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: molecular-dynamics simulations.

Authors:  Craig M Shepherd; Hans J Vogel; D Peter Tieleman
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

Review 2.  Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold.

Authors:  Brandon Findlay; George G Zhanel; Frank Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

3.  Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide.

Authors:  Hyung-Sik Won; Su-Jin Kang; Wahn-Soo Choi; Bong-Jin Lee
Journal:  Mol Cells       Date:  2010-11-23       Impact factor: 5.034

4.  Functional genetic and biophysical analyses of membrane disruption by human adenovirus.

Authors:  Crystal L Moyer; Christopher M Wiethoff; Oana Maier; Jason G Smith; Glen R Nemerow
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

5.  Rational combinatorial design of pore-forming beta-sheet peptides.

Authors:  Joshua M Rausch; Jessica R Marks; William C Wimley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

6.  Ultrashort antibacterial and antifungal lipopeptides.

Authors:  Arik Makovitzki; Dorit Avrahami; Yechiel Shai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-12       Impact factor: 11.205

7.  Molecular dynamics investigation of the influence of anionic and zwitterionic interfaces on antimicrobial peptides' structure: implications for peptide toxicity and activity.

Authors:  Himanshu Khandelia; Yiannis N Kaznessis
Journal:  Peptides       Date:  2005-12-01       Impact factor: 3.750

8.  Characterization of a potent antimicrobial lipopeptide via coarse-grained molecular dynamics.

Authors:  Joshua N Horn; Jesse D Sengillo; Dejun Lin; Tod D Romo; Alan Grossfield
Journal:  Biochim Biophys Acta       Date:  2011-07-28

9.  Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity.

Authors:  Ramesh Rathinakumar; William F Walkenhorst; William C Wimley
Journal:  J Am Chem Soc       Date:  2009-06-10       Impact factor: 15.419

10.  Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides.

Authors:  Nathaniel P Chongsiriwatana; James A Patch; Ann M Czyzewski; Michelle T Dohm; Andrey Ivankin; David Gidalevitz; Ronald N Zuckermann; Annelise E Barron
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.